Previous Article | Next Article 
Journal of Virology, February 1999, p. 1447-1452, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Amplification of the Inflammatory Cellular Redox State by Human
Immunodeficiency Virus Type 1-Immunosuppressive Tat and gp160
Proteins
Abderrahim
Lachgar,1
Neso
Sojic,2
Stephane
Arbault,2
Delphine
Bruce,2
Alain
Sarasin,2
Christian
Amatore,2
Bernard
Bizzini,1
Daniel
Zagury,1 and
Monique
Vuillaume2,*
Université Pierre et Marie
Curie,1 and
URA 1679 et UPR 42 CNRS,
Ecole Normale Supérieure,2 Paris, France
Received 16 June 1998/Accepted 12 November 1998
 |
ABSTRACT |
In the course of our studies on oxidative stress as a component of
pathological processes in humans, we showed that microintrusion into
cells with microcapillary and ultramicroelectrochemical detection could mimic many types of mechanical intrusion leading to an
instant (0.1 s) and high (some femtomoles) burst release of
H2O2. Specific inhibitors of NADPH enzymes seem
to support the assumption that this enzyme is one of the main targets
of our experiments. Also, human immunodeficiency virus type 1 (HIV-1)
gp160 inhibits the cooperative response of uninfected T cells as well
as Tat protein release by infected cells does. In this study, we
analyzed in real time, lymphocyte per lymphocyte, the T-cell response
following activation in relation to the redox state. We showed that the immunosuppressive effects of HIV-1 Tat and gp160 proteins and oxidative
stress are correlated, since the native but not the inactivated Tat and
gp160 proteins inhibit the cellular immune response and enhance
oxidative stress. These results are consistent with a role of the
membrane NADPH oxidase in the cellular response to immune activation.
 |
INTRODUCTION |
Survival of all living entities is
dependent on the modulation of cell metabolism in response to
environmental changes and challenges. In higher organisms such
phenomena include a defensive response to "stresses" (injury,
viruses, and pathogens). Organisms require a rapidly acting system to
detect and combat such potentially life-threatening occurrences.
Meanwhile, it is known that human metabolism often is not capable of
controlling the damaging effects of reduced and reactive oxygen species
(ROS), which contribute to several inflammatory processes, apoptosis,
carcinogenesis, aging, and human immunodeficiency virus (HIV)
expression (2, 15, 18, 24, 28, 30, 33, 34, 37). Our previous data showed that microintrusion with a microcapillary into a single cell, followed by ultramicroelectrochemical detection (4), could mimic many types of mechanical intrusion (e.g., bacteria, virus
internalization, asbestos, and endocytocis) leading to an instant (0.1 s) and high (some femtomoles) burst release of
H2O2. The effects of specific inhibitors of
NADPH oxidase or NADPH oxidase-like enzymes seem to support the
assumption that this membranic enzyme may be, at least, one of the main
targets in our experiments that involved either human fibroblast cell
lines or peripheral blood mononuclear cells (PBMCs) from healthy
patients and cells from AIDS patients (3, 5). One of these
inhibitors endowed with convenience efficacy (maximum efficiency versus
minimum cytotoxicity) is phenylarsine oxide (PAO). It is considered to
be a specific inhibitor of the NADPH oxidase in human neutrophils
(22) and was shown to inhibit phorbol myristate acetate
(PMA)-induced oxygen burst in macrophages and neutrophils, the tumor
necrosis factor alpha (TNF-
)-induced activation of NF-
B in ML1-a
cells, and cytosolic protein kinase C activity in unstimulated
neutrophils (6, 8, 25, 26). In the present study we have
investigated the mechanisms displayed by the virus in producing
oxidative stress. Indeed, in HIV type 1 (HIV-1)-infected individuals,
pathogenic processes may be generated by infected cells, which,
following immune activation, induce both premature cytolysis and
release of virions (14). However, the low percentage of
infected cells in the host cannot per se account for the overall immune
impairment (2, 7, 27). HIV-1-induced immune disorders should
also involve uninfected cells resulting in a progressive T-cell loss by
apoptosis or immunosuppression following immune activation with the
possible loss of innate immunity. We, and others, have investigated the
roles played by two major HIV-1 components, namely the structural Env
gp160 and the regulatory Tat proteins, in HIV-1 pathogenesis (29,
38, 39). We have previously shown that gp160 and Tat proteins
exert, in a dose-dependent manner, an antiproliferative effect on
normal in vitro-activated PBMCs. It is known that Env gp160 or gp120 is
present in the extracellular compartment as a soluble molecule released
by infected cells after their lysis or as the external protein on free
virions causing CD4 cell anergy of uninfected immune cells
(27). Tat is an early protein synthesized by infected cells
during HIV-1 replication (9, 40). This protein is known to
play a major regulatory role in these cells, activating viral
replication and blocking cellular metabolism (38, 40).
Furthermore, in acute HIV-1 infection with a high replication rate, Tat
is released into the extracellular compartment, and at high
concentrations, acting as a true toxin, Tat proteins enter noninfected
cells either by recognizing integrine receptors or by cell-to-cell
contact (11, 12). Uptake of exogenous Tat may cause
metabolic changes in noninfected immune cells, leading to
immunosuppression as a result of inhibition of the proliferation of
antigen-stimulated T cells (21, 38) or to apoptosis
(35).
Previous studies have shown that HIV-1 Tat protein could alter the
cellular redox state by potentiating the TNF-induced NF-
B activation
(36). Additional data show that both antioxidants and
dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative
damage to human monocytic cells (23).
It has also been reported that, as for many other pathological
processes, HIV-1 infection is dependent on both the balance between
alteration of cellular metabolism and the body response to the induced
environmental changes. Therefore, to counteract the cellular damaging
effects of HIV-1 Tat and gp160 proteins it was necessary to develop a
technique which would allow rapid detection of deleterious effects. The
very sensitive method that we have previously developed (3, 4,
5) can be used successfully to analyze, at the level of an
individual lymphocyte, the pathogenic role of a Tat- or gp160-induced
oxidative stress on cell physiology by using particular inhibitory
drugs to quench the effects induced in this way.
The aim of the present study was twofold. First, we sought to evaluate
the early relationship between an increased oxidative stress response
and the immunosuppressive effects of HIV-1 Tat and gp160 proteins,
which inhibit the normal immune response. For this, the redox
response of Tat- or gp160-exposed cells was measured cell per cell, in
real time (0.1 to 20 s for the full response). Second, we looked
for a possible way of reducing ex vivo the damaging effects of HIV-1
Tat and gp160 proteins by combining microelectrochemical and
immunological methods.
 |
MATERIALS AND METHODS |
Viral proteins.
HIV-1 Tat protein was prepared either by
DEAE chromatography followed by gel filtration or by solubilization in
6 M guanidine, HCl-containing buffer followed by chromatography on
nickel chelate agarose (NTA; Qiagen, Hilden, Germany). Tat cDNA
expression vectors were derived from human T-cell lymphotropic virus
type IIIB (HTLVIIIB) pCV1. The biological
activity of Tat protein was determined by using the chloramphenicol
acetyltransferase (CAT) assay on HeLa cells (23).
Inactivated Tat protein (iTat) was obtained by using glutaraldehyde in
a procedure similar to that used for the preparation of toxoids from
bacterial toxins. Abolition of the biological activity of Tat was
ascertained by the CAT assay (23). Recombinant gp160, Nef,
and Vpr proteins from HIV-1 LAI were a gift from Institut Mérieux
(Lyon, France), and inactivated gp160 (igp160) and heat-inactivated Tat
(h-Tat) were prepared by heating native proteins for 5 min at 100°C.
Cells.
PBMCs were isolated on Ficoll Hypaque from
heparinized blood samples taken from healthy donors.
Cell activation.
PBMCs (106 cells/ml) were
stimulated by superantigen staphyloccal enterotoxin type B (SEB)
(1 mg/ml) in RPMI medium containing 10% human serum AB and
cultured in 96-well round-bottomed culture plates for 12 to 15 h
for the study of oxidative stress or for 3 days for the T-cell
proliferation assay.
T-cell proliferation was measured by the addition of 1 µCi of
[3H]thymidine per well during the last 18 h of
culture time, followed by cell harvesting and the quantification of
[3H]thymidine incorporation with a
counter.
H2O2 detection by ultramicroelectrodes on
single PBMCs.
The various methods used to prepare platinized
carbon-fiber ultramicroelectrodes and detect ex vivo
H2O2 production by a single human cell have
been previously described (3-5). In the present experiments, platinized (maximum electrodeposition current,
500 nA)
carbon fiber ultramicroelectrodes (10 µm diameter) were used (Fig.
1) (4, 5).
H2O2 detection (a few femtomoles) was carried out by amperometry (applied potential of +600 mV/the reference electrode Ag-AgCl) by one of our methods, which consists of puncturing the cell membrane with a closed-tip micropipette (diameter, <0.5 µm)
while the detecting ultramicroelectrode is set at 1 to 5 µm above the
membrane puncture. Angles of microelectrode position versus the cell
surface, and of micropipette intrusion into the cell, have been
precisely defined (45°) and were held constant all through
experiments. Since this method requires adherent cells, measurements
were performed on cells immobilized in petri dishes in the presence of
phosphate-buffered saline (PBS) (3). For this, petri dishes
were coated for 1 h with 250 µl of poly-L-lysine (1 mg/ml) (P1524; Sigma) dissolved into PBS. Aliquots of about 20,000 lymphocytes from cell culture were deposited on petri dishes. After 10 min, cells were washed and only adherent cells were further treated.
Under well-defined conditions, in order to prevent the cells from being
damaged in the absence of growth medium, adherent cells in each petri
dish were used for only 20 min. As previously stated (4),
the cell response consists essentially in a flux of activated oxygen
species resulting in further production of O2·
derivatives, among which is
H2O2.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of the microelectrochemical
device for the determination of H2O2 production
by a single cell in real time. Two three-axis micromanipulator arms
(3) are used to set up the ultramicroelectrode
(1) and microcapillary tips above the cell surface
(2). The cellular response induced by the microcapillary
introduction into the lymphocyte is recorded on an amperometer at a
fixed potential of +600 mV/(Ag-AgCl) imposed between the
ultramicroelectrode and the reference electrode Ag-AgCl (4)
by the potentiostat. The angle of the ultramicroelectrode and the
microcapillary to the cell is, once and for all, fixed at 45°.
|
|
Inhibition of NADPH oxidase activity by PAO.
We and others
have shown that H2O2 production in activated
PBMCs was dependent on NADPH oxidase activation (3). Such
production is highly increased in HIV-1-infected cells (22,
28). In order to verify whether the exogenous immunosuppressive
HIV-1 Tat and gp160 proteins were responsible for the
H2O2 increase, experiments similar to those
described above were carried out with PAO at a concentration capable of
inhibiting up to 75 to 85% of the H2O2 production (3). SEB-activated cells were incubated for
1 h with 25 µM freshly prepared PAO (the stock solution is
prepared daily in 95% ethanol at a final concentration of 0.4 M, and
the solution is sonicated for 30 min with a Branson 1210 sonicator). Cells were then washed three times with PBS, and the cell membrane was
punctured. Routine controls through all experiments included determination of: (i) cell viability (measured within 1 h for PAO
at 1 mM); (ii) cellular adhesion; and (iii) recovery of electrochemical response for H2O2 production when fresh cells
not incubated with catalase or PAO were immediately analyzed. Samples
(at least 30 cells) from the various cell preparations were randomly
tested over the ensuing 1 day in order to eliminate any possible
"time effect." Data are the mean values of the different
measurements. At the end of each set of experiments, the
ultramicroelectrodes were retested to assess measurement reliability.
 |
RESULTS |
Antiproliferative activity of HIV-1 Tat and gp160 proteins.
The proliferative response exhibited by SEB-activated normal PBMCs was
markedly reduced when T-cell activation was performed in the presence
of HIV-1 Tat or HIV-1 gp160 (Fig. 2). As
is already well known, this immunosuppressive effect is dose dependent
(data not shown) and exhibits a magnitude of 80% at 1 µM for Tat and at 0.03 µM for gp160. HIV-1 p24gag (p24)
(0.42 µM), Nef (1 µM), and Vpr (1 µM) proteins were
used as controls since they were devoid of any immunosuppressive
activity even at high concentrations. More interestingly, cells
activated and cultured in the presence of glutaraldehyde-inactivated
Tat, heat-inactivated Tat, or gp160 showed normal proliferation, as was
the case for the control cells without any added HIV-1 proteins. This
result supports the assumption that the immunosuppressive activity of
the HIV-1 proteins Tat and gp160 is related to their biologically
active forms and is not only dependent on the amino acid sequence,
since the amino acid sequence is not modified by the inactivation
process. The inactivated proteins remained antigenic and
immunogenic as ascertained by enzyme-linked immunosorbent assay
(ELISA) with the native antigens for antibody detection (Fig. 2).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 2.
Inhibition of T-cell proliferation by HIV-1 Tat and
gp160. SEB-activated PBMCs were cultured for 3 days in the presence of
HIV-1 gp160 (0.03 µM) or Tat protein (1 µM), or p24 (0.42 µM) or
Nef (1 µM), or Vpr (1 µM) as HIV-1 protein controls, or HSA (0.03 µM). Concomitantly, cell proliferation was measured in the presence
of iTat, h-Tat, or igp60 to corroborate that the anti-proliferative
effects of the tested HIV-1 proteins are associated with the native
forms of Tat and gp160 and not only to their amino acid sequences,
since the inactivation procedures used preserve the protein structures
(as measured by ELISA with specific antibodies) even if they inactivate
the biological activities of the proteins.
|
|
HIV-1 gp160- and Tat-induced oxidative stress and
immunosuppression.
To investigate ROS production (in our case,
mostly H2O2 production) and its
compartmentalization, large number of cells usually have to be
processed to obtain cell extracts by sonication and centrifugation.
These treatments must be carried out for a relatively long period of
time (about 30 min) compared to the half-life of H2O2 (which has the longest half-life compared
with that of O2·
or OH·),
which may impair the interpretation of results. Consequently, we have
developed a method by using ultramicroelectrodes (electrodes of
micrometer dimensions) that permitted us to detect superoxide derivatives such as H2O2 by a specific
electrochemical device after introduction of a microcapillary (<0.5
µm) into a discrete site of a single living cell (Fig. 1). Figure
3 shows that the cellular response
exhibits a peak shape with a maximum height (in picoamperes) reached in
less than 1 s and a total area (electric charge, Q, in picocoulombs)
spanned in less than 40 s. The total amount of the
H2O2 detected is in the range of femtomoles,
i.e., about 10 mM versus cellular volume. This "concentration,"
calculated for various human fibroblast cell lines (normal, simian
virus 40 transformed, and Xeroderma pigmentosum) as well as
for human PBMCs, isolated lymphocytes, and promonocytic cell lines,
cannot preexist within a living cell because its magnitude is probably incompatible with life. Consequently, this H2O2
production should be considered an active neoproduction due to the
membrane stress at the time of cell puncture. This has led us to
consider microcapillary introduction as a model that mimics effects
similar to those due to particle introduction (virus, bacteria,
asbestos) into a cell and to investigate the possible role of the
cytoplasmic membrane NADPH oxidase in these effects. Incubation of
cells in the presence of various inhibitors of the activation of
different components of NADPH oxidase prompted us to postulate that an
NADPH oxidase-like enzyme may at least in part be involved in the
observed H2O2 generation.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Electrochemical detection of
H2O2 production by immobilized activated human
T cells incubated (15 h) with HIV-1 p24 (0.42 µM), Nef (1 µM), Vpr
(1 µM), gp160 (0.03 µM), Tat (1 µM), or HSA (0.03 µM). (a)
Kinetics of peaks obtained from averaged cellular responses of
activated control T cells ( ) and T cells incubated with p24 ( ),
gp160 (---), or Tat (---). (b)
Effects of p24, gp160, Tat, Nef, Vpr, igp160, iTat, h-Tat, and HSA on
the maximum peak current detected by amperometry on activated T cells.
(c) Effects of p24, gp160, igp160, Tat, Nef, Vpr, iTat, h-Tat, and HSA
on the total peak charge detected by amperometry on activated T cells.
Values are means ± standard errors, and 50 to 80 cells were
tested for each sample.
|
|
In the present study we used lymphocytes from healthy individuals to
evaluate the significance for HIV-1-associated immunopathogenesis
of
pro-oxidant conditions and the possible NADPH oxidase
dependent-inflammatory
response which are induced by the
immunosuppressive isolated HIV-1
proteins Tat and
gp160.
Figure
3 shows the mean values for peak current and peak charge
(surface area), as detected by our ultramicroelectrode assay,
for
various experiments with the HIV-1 proteins p24 (0.42 µM),
Tat (1 µM), gp160 (0.03 µM), Nef (1 µM), and Vpr (1 µM) and human
serum albumin (HSA) (0.03 µM). It can be concluded from this that
activated lymphocytes from healthy individuals which have been
incubated with HSA, p24, Nef, or Vpr exhibit a peak current and
a peak
charge which are similar to those of the control activated
cells. In
contrast, cells incubated with Tat or gp160 exhibit
a peak current and
a peak charge which are about two times higher
than those of control
cells. The redox state disorders as well
as immunosuppressive effects
exhibited by either Tat or gp160
are associated with their native form
since igp160, h-Tat, and
iTat do not induce
H
2O
2 production increase (Fig.
3b and c) or
suppressive effects (Fig.
2), as was the case with the native
proteins.
The reported data are in agreement with the observation
that HIV-1 Tat
and gp160 proteins contribute to the hyperactivation
of the cellular
inflammation state. Furthermore, responses to
Tat and gp160 are dose
dependent: at concentrations of 5 µg/ml
of Tat or 2.5 µg/ml of
gp160, H
2O
2 production was not
affected.
Effects of PAO on HIV-1 Tat- and HIV-1 gp160-induced oxidative
stress.
In order to determine whether NADPH oxidase or NADPH
oxidase-like enzymes were possible targets for the amplified oxidative stress observed either before or after incubation of cells with Tat or
gp160 and induced by microcapillary introduction, we have studied the
effect of PAO, a known specific NADPH oxidase inhibitor (22). We have first verified that at a concentration of 25 µM PAO inhibits 75 to 85% of the oxidative stress response of
circulating activated leukocytes. As we have previously shown with
HIV-1-infected macrophages, PBMCs, and NF-
B induction in U1
activated cells (3), 25 µM PAO decreased the level of Tat-
or gp160-induced H2O2 production to that of
activated control cells (Fig. 4). These results show that HIV-1 immunosuppressive Tat and gp160 proteins may
influence cellular metabolism, at least in part, through the membrane
NADPH oxidase of lymphocytes, which enhances cellular oxidative
response.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of PAO (1-h incubation, 25 µM concentration)
on the maximum peak current (a) and the total peak charge (b) detected
by amperometry on activated normal T cells and on T cells incubated
with gp160 or Tat. Values are means ± standard errors.
|
|
 |
DISCUSSION |
The increase of oxidative stress in activated PBMCs as in PBMCs
originating from HIV-1 patients is consistent with the involvement of
oxidative stress in the cellular immune response (3, 20). Furthermore, it has been well documented by several groups of investigators that virus production is related through NF-
B
activation to ROS level (1, 3, 13, 17).
Herewith, we show that HIV-1 Tat and gp160 are associated with a very
early increase of H2O2 production as measured
by our ultramicroelectrochemical technique. As expected, heat-denatured Tat as well as nonimmunosuppressive HIV-1 proteins, such as Nef, Vpr,
and p24gag, and the unrelated HSA did not
increase the oxidative stress response (Fig. 3). Our studies were
undertaken on the basis of the regulatory action of Tat protein in
HIV-1 production by activation of NF-
B and on the involvement of Tat
and gp160 in apoptosis as observed in the course of HIV infection for
both infected and uninfected cells (28).
In this connection, it should be stressed that Tat can, at low doses,
increase the production of proinflammatory chemokines MIP1
, MIP1
,
and Rantes, whereas at high doses, it increases that of the
immunosuppressive cytokine alpha interferon (38, 39). These
elements are constitutive of the activation state of the immune cell,
which is in part characterized by production of
O2·
and/or H2O2,
and thus mimic the condition of the inflammatory cell (3, 4,
32).
Since the inactivated Tat and gp160 molecules did not induce
immunosuppression or enhance oxidative stress, they can be used as
immunogens to induce specific antibodies and counteract the damaging
effect of infection (16). We have previously shown that Tat
inhibited cell proliferation (immunosuppression) by 85%, which
inhibition could be counteracted by treating Tat-treated cells with
anti-Tat. In the present study we determined that the Tat-induced
increase of oxidative stress can also be abolished by Tat treatment
with anti-Tat antibodies (data not shown). This latter result is
consistent with the assumption that the Tat-induced immunosuppression
(inhibition of cell proliferation) is related to the capacity of Tat to
increase oxidative stress.
Herewith, it has also been shown that the redox imbalance is correlated
in part to an increase of NADPH oxidase activity, since PAO, a
well-known inhibitor of this enzyme (19), could restore the
cell redox state that was disturbed by Tat or gp160 action. We are
currently investigating whether the cellular redox state impairment by
HIV-1 Tat and gp160 can be reverted by the use of NADPH oxidase
inhibitors at physiological concentrations.
Finally, these results suggest that (i) the mechanisms leading to
HIV-1-associated immunosuppression should be related, at least in part,
to the overall abnormal cellular oxidative stress, and (ii) new ways of
combatting immunosuppression may involve the use of drugs quenching the
oxidative stress induced by the effect of gp160 and Tat proteins in the
course of HIV-1 infection.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from URA 1679 and UPR 42 CNRS,
from Ultimatech CNRS, and from the Biomed II-EU program. The French
Ministère de l'Education Nationale, de l'Enseignement Supérieur, de la Recherche et de la Technologie provided doctoral fellowships to N.S., S.A., and D.B. respectively, and Biomed II provided post-doctoral fellowships to S.A. and N.S. This work was also
financially supported by grants from NEOVACS (Paris) and l'Association
pour la Recherche sur le Sida to A.L.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: UPR42 CNRS,
Département de Chimie, Ecole Normale Supérieure,
75005 Paris, France. Phone: 33-1-44323641. Fax: 33-1-44323325. E-mail: Monique.Vuillaume{at}ens.fr.
 |
REFERENCES |
| 1.
|
Alcami, J.,
T. Lain de Lera,
L. Folguera,
M. A. Pedraza,
J. M. Jacqué,
F. Bachelerie,
A. R. Noriega,
R. T. Hay,
D. Harrich,
R. B. Gaynor,
J.-L. Virelizier, and F. Arenzana-Seisdedos.
1995.
Absolute dependence on B responsive elements for initiation and TaT-mediated amplification of HIV transcription in blood CD4 T lymphocytes.
EMBO J.
14:1552-1560[Medline].
|
| 2.
|
Ameisen, J. C., and A. Capron.
1991.
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis.
Immunol. Today
4:102-105.
|
| 3.
|
Arbault, S.,
M. Edeas,
S. Legrand-Poels,
N. Sojic,
C. Amatore,
J. Piette,
M. Best-Belpomme,
A. Lindebaum, and M. Vuillaume.
1997.
Phenylarsine oxide inhibits ex vivo HIV-1 expression.
Biomed. Pharmacother.
51:430-438[Medline].
|
| 4.
|
Arbault, S.,
P. Pantano,
J. Jankowski,
M. Vuillaume, and C. Amatore.
1995.
Monitoring an oxidative stress mechanism at single human fibroblast.
Anal. Chem.
67:3382-3390[Medline].
|
| 5.
|
Arbault, S.,
P. Pantano,
N. Sojic,
C. Amatore,
M. Best-Belpomme,
A. Sarasin, and M. Vuillaume.
1997.
Activation of the NADPH oxidase in human fibroblasts by mechanical intrusion of a single cell with an ultramicroelectrode.
Carcinogenesis
18:569-574[Abstract/Free Full Text].
|
| 6.
|
Ballotti, R.,
S. Tartare,
A. Chauvel,
J. Scimeca,
F. Alengrin,
C. Filloux, and E. Van Obberghem.
1991.
Phenylarsine oxide stimulates a cytosolic kinase activity and glucose transport in mouse fibroblasts.
Exp. Cell Res.
197:300-306[Medline].
|
| 7.
|
Clerici, M.,
N. I. Stocks,
R. A. Zajac,
R. N. Boswell,
D. R. Lucey,
C. S. Via, and G. M. Shearer.
1989.
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic human immunodeficiency virus-seropositive patients.
J. Clin. Investig.
84:1892-1899.
|
| 8.
|
Conde, M.,
M. D. Chiara,
E. Pintado, and F. Sobrino.
1995.
Modulation of phorbol ester-induced respiratory burst by vanadate, genistein and phenylarsine oxide in mouse macrophages.
Free Radic. Biol. Med.
18:343-348[Medline].
|
| 9.
|
Cullen, B. R.
1991.
Regulation of HIV-1 gene expression.
FASEB J.
5:2361-2368[Abstract].
|
| 10.
| Cullen, B. R. 1995. Regulation of HIV-1 gene
expression. AIDS 9(Suppl. A):S19-S32.
|
| 11.
|
Ensoli, B.,
G. Barillari,
S. Z. Salahuddin,
R. C. Gallo, and F. Wong-Staal.
1990.
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
Nature
345:84-86[Medline].
|
| 12.
|
Ensoli, B.,
R. Gendelman,
P. Markham,
V. Fiorelli,
S. Colombini,
M. Raffeld,
A. Cafaro,
H. K. Chang,
J. N. Brady, and R. C. Gallo.
1994.
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.
Nature
371:674-680[Medline].
|
| 13.
|
Franzoso, G.,
V. Bours,
S. Park,
M. Tomita-Yamagushi,
K. Kelly, and U. Siebenlist.
1992.
Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.
Nature
359:207-210.
|
| 14.
|
Gallo, R. C.,
S. Z. Salahuddin,
M. Popovic,
G. M. Shearer,
M. Kaplan,
B. F. Haynes,
T. J. Palker,
R. Redfield,
J. B. OleskeSafai,
G. White,
P. Foster, and P. D. Markham.
1984.
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk of AIDS.
Science
224:500-503[Abstract/Free Full Text].
|
| 15.
|
Gougeon, M. L.,
S. Garcia,
J. Heeney,
R. Tschopp,
H. Lecoeur,
L. V. Guétard,
C. Dauguet, and L. Montagnier.
1993.
Programmed cell death in AIDS-related HIV and SIV infections.
AIDS Res. Hum. Retroviruses
9:553-563[Medline].
|
| 16.
|
Gringeri, A.,
E. Santagostino,
M. Mucha-Perja,
P. M. Mannucci,
J. F. Zagury,
B. Bizzini,
A. Lachgar,
M. Carcagno,
J. Rappaport,
M. Criscuolo,
W. Blattner,
A. Burny,
D. Zagury, and R. C. Gallo.
1998.
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1 infected patients.
J. Hum. Virol.
1:293-298.
[Medline] |
| 17.
|
Henkel, T.,
S. Machleidt,
I. Alkalay,
M. Krönke,
Y. Ben-Neriah, and P. A. Baeuerle.
1993.
Rapid proteolysis of IkB- is necessary for activation of transcription factor NF-kB.
Nature
365:182-185[Medline].
|
| 18.
|
Henson, P. M.,
J. E. Henson,
C. Fittschen,
G. Kimani,
D. L. Bratton, and D. W. H. Riches.
1988.
Basic principles and clinical correlates. Phagocytic cells: degranulation and secretion, p. 363-390.
In
J. L. Gallin, I. M. Goldestein, and R. Synderman (ed.), Inflammation. Raven Press Ltd., New York, N.Y.
|
| 19.
|
Holland, L. E.,
J. L. Buthod,
C. D. Kowal, and T. K. Antonucci.
1992.
Characterization of oxophenarsine as a potential antiviral agent for AIDS.
AIDS Res. Hum. Retroviruses
8:1717-1722[Medline].
|
| 20.
|
Israel, N., and M. A. Gougerot-Pocidalo.
1997.
Oxidative stress in human immunodeficiency virus infection.
Cell Mol. Life Sci.
53:864-870[Medline].
|
| 21.
|
Lachgar, A.,
J. Bernard,
B. Bizzini,
A. Astgen,
H. Le Coq,
M. Fouchard,
V. Chams,
M. Feldman,
A. Burny, and J. F. Zagury.
1996.
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies.
Biomed. Pharmacother.
50:13-18[Medline].
|
| 22.
|
Le Cabec, V., and I. Maridonneau-Parini.
1995.
Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the enzyme subunits.
J. Biol. Chem.
270:10631-10639[Abstract/Free Full Text].
|
| 23.
|
Lu, J., and C. Jiang.
1992.
Detergents inhibit chloramphenicol acetyl transferase.
BioTechniques
12:643-644[Medline].
|
| 24.
|
Miesel, M.,
M. Kurpisz, and H. Kröger.
1996.
Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase.
Free Radic. Biol. Med.
20:75-83[Medline].
|
| 25.
|
Morales, G.,
Y. Minami,
E. Luong,
R. D. Klausner, and L. E. Samelson.
1990.
Tyrosine phosphorylation in T cells is regulated by phosphatase activity: studies with phenylarsine oxide.
Proc. Natl. Acad. Sci. USA
87:9255-9259[Abstract/Free Full Text].
|
| 26.
|
Oetken, C.,
M. von Willebrand,
M. Autero,
R. Tapini,
L. C. Anderson, and T. Mustelin.
1992.
Phenylarsine oxide augments tyrosine phosphorylation in hematopoietic cells.
Eur. J. Haematol.
49:208-214[Medline].
|
| 27.
|
Oyaizu, N.,
N. Chirmule,
V. S. Kalyanaraman,
W. W. Hall,
R. Pahwa,
M. Shuster, and S. Pahwa.
1990.
Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA.
Proc. Natl. Acad. Sci. USA
87:2379-2383[Abstract/Free Full Text].
|
| 28.
|
Pace, G. W., and C. D. Leaf.
1995.
The role of oxidative stress in HIV disease.
Free Radic. Biol. Med.
19:523-530[Medline].
|
| 29.
|
Picard, O.,
J. Bernard,
A. Lachgar,
L. S. Fall,
M. Carlotti,
A. Achour,
C. Carelli,
J. J. Salaun,
J. P. Mbika,
Z. Lurhuma, et al.
1992.
Removal of gp160 induced bio-hazards for a safe AIDS vaccine candidate.
Biomed. Pharmacother.
46:353-357[Medline].
|
| 30.
|
Sacks, T.,
C. F. Moldow,
P. R. Craddock,
T. K. Bowers, and H. S. Jacob.
1978.
Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model for immune damage.
J. Clin. Investig.
61:1161-1167.
|
| 31.
|
Sandstrom, P. A.,
B. Robert,
T. M. Folks,
T. M. Buttke, et al.
1993.
HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis.
AIDS Res. Hum. Retroviruses
9:1107-1317[Medline].
|
| 32.
|
Schulze-Osthoff, K.,
M. K. Bauer,
M. Vog, and S. Wesselborg.
1997.
Oxidative stress and signal transduction.
Int. J. Nutr. Res.
67:336-342.
|
| 33.
|
Vuillaume, M.,
L. Daya-Grosjean,
P. Vincens,
J. L. Pennetier,
P. Tarroux,
A. Baret,
R. Calvayrac,
A. Taieb, and A. Sarasin.
1992.
Striking differences in cellular catalase activity between two DNA repair deficient diseases: Xeroderma pigmentosum and Trichothiodystrophy.
Carcinogenesis
13:321-328[Abstract/Free Full Text].
|
| 34.
|
Vuillaume, M.,
R. Calvayrac,
M. Best-Belpomme,
P. Tarroux,
M. Hubert,
Y. Decroix, and A. Sarasin.
1986.
Deficiency in the catalase activity of Xeroderma pigmentosum and SV40-transformed human cell lines.
Cancer Res.
46:538-544[Abstract/Free Full Text].
|
| 35.
|
Westendorp, M. O.,
R. Frank,
C. Ochsenbauer,
K. Stricker,
J. Dhein,
H. Walczak,
K. M. Debatin, and P. H. Krammer.
1995.
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Nature
375:497-500[Medline].
|
| 36.
|
Westendorp, M. O.,
V. A. Shatrov,
K. Schulze-Osthoff,
R. Frank,
M. Kraft,
M. Los,
P. H. Krammer,
W. Droge, and V. Lehmann.
1995.
HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state.
EMBO J.
14:546-554[Medline].
|
| 37.
|
Yokoi, I.,
J. Toma,
J. Liu,
H. Kabuto, and A. Mori.
1995.
Adenosines scavenged hydroxyl radicals and prevented postraumatic epilepsy.
Free Radic. Biol. Med.
19:473-481[Medline].
|
| 38.
|
Zagury, D.,
A. Lachgar,
V. Chams,
L. S. Fall,
J. Bernard,
J. F. Zagury,
B. Bizzini,
A. Gringeri,
E. Santagostino,
J. Rappaport,
M. Feldman,
A. Burny, and R. C. Gallo.
1998.
Interferon alpha and tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.
Proc. Natl. Acad. Sci. USA
95:3851-3856[Abstract/Free Full Text].
|
| 39.
|
Zagury, D.,
A. Lachgar,
V. Chams,
L. S. Fall,
J. Bernard,
J. F. Zagury,
B. Bizzini,
A. Gringeri,
E. Santagostino,
J. Rappaport,
M. Feldman,
A. Burny, and R. C. Gallo.
1998.
C-C chemokines, pivotal in protection against HIV type 1 infection.
Proc. Natl. Acad. Sci. USA
95:3857-3861[Abstract/Free Full Text].
|
| 40.
|
Zagury, D.,
J. Bernard,
R. Leonard,
R. Cheynier,
M. Feldman,
P. S. Sarin, and R. C. Gallo.
1986.
Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS.
Science
231:850-853[Abstract/Free Full Text].
|
Journal of Virology, February 1999, p. 1447-1452, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ho, H.-Y., Cheng, M.-L., Weng, S.-F., Chang, L., Yeh, T.-T., Shih, S.-R., Chiu, D. T.-Y.
(2008). Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J. Gen. Virol.
89: 2080-2089
[Abstract]
[Full Text]
-
Kline, E. R., Kleinhenz, D. J., Liang, B., Dikalov, S., Guidot, D. M., Hart, C. M., Jones, D. P., Sutliff, R. L.
(2008). Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am. J. Physiol. Heart Circ. Physiol.
294: H2792-H2804
[Abstract]
[Full Text]
-
Arbault, S., Sojic, N., Bruce, D., Amatore, C., Sarasin, A., Vuillaume, M.
(2004). Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis
25: 509-515
[Abstract]
[Full Text]
-
Geiben-Lynn, R., Kursar, M., Brown, N. V., Addo, M. M., Shau, H., Lieberman, J., Luster, A. D., Walker, B. D.
(2003). HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin Family. J. Biol. Chem.
278: 1569-1574
[Abstract]
[Full Text]
-
Perez, O. D., Nolan, G. P., Magda, D., Miller, R. A., Herzenberg, L. A., Herzenberg, L. A.
(2002). Motexafin gadolinium (Gd-Tex) selectively induces apoptosis in HIV-1 infected CD4+ T helper cells. Proc. Natl. Acad. Sci. USA
99: 2270-2274
[Abstract]
[Full Text]
-
Bureau, C., Bernad, J., Chaouche, N., Orfila, C., Beraud, M., Gonindard, C., Alric, L., Vinel, J.-P., Pipy, B.
(2001). Nonstructural 3 Protein of Hepatitis C Virus Triggers an Oxidative Burst in Human Monocytes via Activation of NADPH Oxidase. J. Biol. Chem.
276: 23077-23083
[Abstract]
[Full Text]